Glenmark expects innovative drugs to drive higher revenue share: CMD

Glenmark Pharmaceuticals CMD Glenn Saldanha said the company expects a higher share of revenue to come from innovative drugs as Glenmark advances its pipeline and focuses on developing differentiated therapies.

Source